Citigroup’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.8M | Sell |
67,200
-34,400
| -34% | -$34.9M | 0.03% | 564 |
|
|
2025
Q4 | $109M | Buy |
101,600
+18,700
| +23% | +$17.9M | 0.05% | 338 |
|
|
2025
Q3 | $63.3M | Sell |
82,900
-1,300
| -2% | -$967K | 0.03% | 545 |
|
|
2025
Q2 | $65.6M | Sell |
84,200
-10,400
| -11% | -$8.08M | 0.03% | 494 |
|
|
2025
Q1 | $78.1M | Sell |
94,600
-8,900
| -9% | -$7.41M | 0.04% | 394 |
|
|
2024
Q4 | $79.9M | Buy |
103,500
+37,900
| +58% | +$31.4M | 0.05% | 353 |
|
|
2024
Q3 | $58.1M | Sell |
65,600
-21,500
| -25% | -$19.3M | 0.03% | 460 |
|
|
2024
Q2 | $78.9M | Sell |
87,100
-35,600
| -29% | -$28.5M | 0.05% | 345 |
|
|
2024
Q1 | $95.5M | Sell |
122,700
-8,100
| -6% | -$5.76M | 0.06% | 287 |
|
|
2023
Q4 | $76.2M | Sell |
130,800
-56,500
| -30% | -$33M | 0.05% | 311 |
|
|
2023
Q3 | $101M | Buy |
187,300
+96,800
| +107% | +$49.9M | 0.08% | 232 |
|
|
2023
Q2 | $42.4M | Buy |
90,500
+41,700
| +85% | +$17.5M | 0.03% | 498 |
|
|
2023
Q1 | $16.8M | Sell |
48,800
-5,800
| -11% | -$1.96M | 0.01% | 905 |
|
|
2022
Q4 | $20M | Sell |
54,600
-57,100
| -51% | -$20.2M | 0.02% | 797 |
|
|
2022
Q3 | $36.1M | Buy |
111,700
+79,200
| +244% | +$25.1M | 0.03% | 503 |
|
|
2022
Q2 | $10.5M | Buy |
32,500
+12,600
| +63% | +$3.78M | 0.01% | 1130 |
|
|
2022
Q1 | $5.7M | Sell |
19,900
-66,000
| -77% | -$17M | ﹤0.01% | 1594 |
|
|
2021
Q4 | $23.7M | Sell |
85,900
-8,000
| -9% | -$2.03M | 0.01% | 913 |
|
|
2021
Q3 | $21.7M | Sell |
93,900
-2,000
| -2% | -$494K | 0.01% | 944 |
|
|
2021
Q2 | $22M | Sell |
95,900
-35,500
| -27% | -$7.13M | 0.01% | 946 |
|
|
2021
Q1 | $24.5M | Sell |
131,400
-11,500
| -8% | -$2.25M | 0.02% | 844 |
|
|
2020
Q4 | $24.1M | Buy |
142,900
+21,300
| +18% | +$3.18M | 0.01% | 924 |
|
|
2020
Q3 | $18M | Sell |
121,600
-20,100
| -14% | -$3.11M | 0.01% | 958 |
|
|
2020
Q2 | $23.3M | Sell |
141,700
-155,100
| -52% | -$23.8M | 0.02% | 745 |
|
|
2020
Q1 | $41.2M | Buy |
296,800
+168,600
| +132% | +$23.2M | 0.04% | 432 |
|
|
2019
Q4 | $16.9M | Buy |
128,200
+4,000
| +3% | +$464K | 0.01% | 1088 |
|
|
2019
Q3 | $13.9M | Sell |
124,200
-31,300
| -20% | -$3.48M | 0.01% | 1165 |
|
|
2019
Q2 | $17.2M | Sell |
155,500
-273,800
| -64% | -$32.2M | 0.01% | 1013 |
|
|
2019
Q1 | $55.7M | Buy |
429,300
+237,300
| +124% | +$28.9M | 0.05% | 355 |
|
|
2018
Q4 | $22.2M | Sell |
192,000
-11,600
| -6% | -$1.3M | 0.02% | 771 |
|
|
2018
Q3 | $21.8M | Buy |
203,600
+80,900
| +66% | +$8.09M | 0.02% | 793 |
|
|
2018
Q2 | $10.5M | Sell |
122,700
-76,900
| -39% | -$6.32M | 0.01% | 1238 |
|
|
2018
Q1 | $15.4M | Buy |
199,600
+50,900
| +34% | +$4.1M | 0.01% | 951 |
|
|
2017
Q4 | $12.6M | Buy |
148,700
+24,400
| +20% | +$2.08M | 0.01% | 1124 |
|
|
2017
Q3 | $10.6M | Buy |
124,300
+21,800
| +21% | +$1.79M | 0.01% | 1196 |
|
|
2017
Q2 | $8.44M | Sell |
102,500
-41,400
| -29% | -$3.38M | 0.01% | 1268 |
|
|
2017
Q1 | $12.1M | Sell |
143,900
-417,500
| -74% | -$33.4M | 0.01% | 1007 |
|
|
2016
Q4 | $41.3M | Buy |
561,400
+213,000
| +61% | +$15.9M | 0.04% | 447 |
|
|
2016
Q3 | $28M | Buy |
348,400
+41,900
| +14% | +$3.35M | 0.03% | 541 |
|
|
2016
Q2 | $24.1M | Buy |
306,500
+95,300
| +45% | +$7.17M | 0.02% | 561 |
|
|
2016
Q1 | $15.2M | Sell |
211,200
-146,400
| -41% | -$11.1M | 0.02% | 751 |
|
|
2015
Q4 | $30.1M | Sell |
357,600
-104,300
| -23% | -$8.66M | 0.03% | 547 |
|
|
2015
Q3 | $38.7M | Sell |
461,900
-65,200
| -12% | -$5.5M | 0.04% | 428 |
|
|
2015
Q2 | $44M | Buy |
527,100
+152,700
| +41% | +$11.6M | 0.04% | 432 |
|
|
2015
Q1 | $27.2M | Sell |
374,400
-473,400
| -56% | -$33.7M | 0.03% | 612 |
|
|
2014
Q4 | $58.5M | Sell |
847,800
-196,000
| -19% | -$13.2M | 0.05% | 352 |
|
|
2014
Q3 | $67.7M | Sell |
1,043,800
-319,200
| -23% | -$20.2M | 0.06% | 303 |
|
|
2014
Q2 | $84.7M | Sell |
1,363,000
-281,000
| -17% | -$16.8M | 0.08% | 228 |
|
|
2014
Q1 | $96.8M | Buy |
1,644,000
+1,259,600
| +328% | +$70.3M | 0.1% | 165 |
|
|
2013
Q4 | $19.6M | Sell |
384,400
-458,300
| -54% | -$22.9M | 0.02% | 779 |
|
|
2013
Q3 | $42.4M | Buy |
842,700
+390,600
| +86% | +$20.4M | 0.04% | 408 |
|
|
2013
Q2 | $22.2M | Buy |
+452,100
| New | +$24.6M | 0.02% | 640 |
|
Other funds holding LLY
VCM
VPM
Citigroup's LLY Position: Q1 2026 in Review
Citigroup increased its Eli Lilly (LLY) stake by 66% in Q1 2026, buying an estimated $438M and bringing the position to 1,091,983 shares worth $1B. The position accounts for 0.43% of the portfolio, ranked #39.
Citigroup first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Citigroup held 1,091,983 shares of Eli Lilly worth $1B as of Q1 2026.
- Citigroup bought 432,352 Eli Lilly shares in Q1 2026, an estimated $438M.
- Eli Lilly made up 0.43% of Citigroup's portfolio in Q1 2026, its #39 holding.
- Citigroup first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.